SCHEMBL4093899

SCHEMBL4093899

CCOC(=O)n1nc(NC(=O)c2ccc(N(C)C)cc2[N+](=O)[O-])c2c1CCNC2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.37
LMNA P02545 2/20 0.37
NPSR1 Q6W5P4 1/20 0.36
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
KMT2A Q03164 4/20 0.33
MEN1 O00255 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
PTGS2 P35354 1/20 0.33
BCHE P06276 1/20 0.33
ACHE P22303 1/20 0.33
USP2 O75604 1/20 0.33
POLB P06746 1/20 0.33
BLM P54132 1/20 0.33
UBE2N P61088 1/20 0.33
BACE1 P56817 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2678604 0.99 MAPT (0.37) MAPTLMNANPSR1SLC6A2SLC6A4
SCHEMBL2677306 0.92 SLC6A2 (0.33) MAPTLMNASLC6A2SLC6A4SLC6A3
Hydrochloric Acid SCHEMBL2677302 0.91 SLC6A2 (0.33) MAPTLMNASLC6A2SLC6A4SLC6A3
SCHEMBL2677539 0.88 MAPT (0.41) MAPTLMNASMN1; SMN2ALDH1A1KMT2A
Hydrochloric Acid SCHEMBL2677535 0.87 MAPT (0.40) MAPTLMNASMN1; SMN2ALDH1A1KMT2A
SCHEMBL2678603 0.87 ALDH1A1 (0.48) MAPTLMNANPSR1SMN1; SMN2ALDH1A1
SCHEMBL2678209 0.86 USP7 (0.34) MAPTLMNASLC6A2SLC6A4SLC6A3
Hydrochloric Acid SCHEMBL2678600 0.86 ALDH1A1 (0.47) MAPTLMNANPSR1SMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL2678205 0.86 USP7 (0.34) MAPTLMNASLC6A2SLC6A4SLC6A3
SCHEMBL1886632 0.84 SIRT6 (0.42) MAPTLMNASMN1; SMN2ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090023745-A1 Substituted Pyrazolo[4,3-c]Pyridine Derivatives Active as Kinase Inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2009-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023745-A1 Substituted Pyrazolo[4,3-c]Pyridine Derivatives Active as Kinase Inhibitors MAP3K3, MAP3K1, MAP3K19 MAPT 2600/4885LMNA 3253/4885NPSR1 4360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.